Global Chronic Lymphocytic Leukemia Market Poised to Reach USD 17.17 Billion by 2029, Growing at a CAGR of 12.7% The Global Chronic Lymphocytic Leukemia (CLL) Market is projected to reach a remarkable valuation of USD 17.17 billion by the year 2029, growing at a compound annual growth rate (CAGR) of 12.7% during the forecast period. This growth is driven by advancements in treatment options,...